{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-088592","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.283101+00:00","generated_at":"2026-05-19T01:32:04.797079+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aptevo files prospectus supplement for ATM offering of up to $8.0M","bullets":["Filed prospectus supplement for ATM offering of up to $8,037,381 in common stock via Roth Capital Partners.","As of June 20, had sold 481,828 shares for gross proceeds of $3,765,143 under the April 2025 Sales Agreement.","Offering is registered under Form S-3 (File No. 333-284969); legal opinion from Paul Hastings LLP filed as exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-088592","json":"https://secwatch.observer/filing/0000950170-25-088592.json","markdown":"https://secwatch.observer/filing/0000950170-25-088592.md","text":"https://secwatch.observer/filing/0000950170-25-088592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025088592/0000950170-25-088592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025088592/apvo-20250620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:32:04.797079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}